Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
GLAND Stock Analysis
Views
Red Flags
Positive
Strong price momentum
High and improving operating margin
Moderate EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Low but stable ROE
Low revenue growth and lower than median growth of industry
Neutral
Moderate dividend yield
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
GLAND Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
GLAND Bulk, Block & Insider Trades
GLAND Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a r... Read More
Key personnel
Mr. Srinivas SaduD
Executive Chairman of the Board
Mr. Shyamakant Giri
Chief Executive Officer
Mr. Ravi Shekhar Mitra
Chief Financial Officer
Mr. Sampath Kumar Pallerlamudi
Compliance Officer, Company Secretary
Ms. Wei HuangD
Non-Executive Director
Dr. Jia Ai (Allen) ZhangD
Non-Executive Director
Mr. Wenjie ZhangD
Non-Executive Director
Mr. Satyanarayana Murthy ChavaliD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Gland Pharma Ltd.?
The current share price of Gland Pharma Ltd. is ₹ 1,703.13 as of 12 Jan 2026.
What is the PE ratio of Gland Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Gland Pharma Ltd. is 35.50 as of the latest financial data.
What is the ROE and ROCE of Gland Pharma Ltd.?
Gland Pharma Ltd. has a Return on Equity (ROE) of 8.61% and a Return on Capital Employed (ROCE) of 10.43% as per the latest financial reports.
What is the market cap of Gland Pharma Ltd.?
The market capitalization of Gland Pharma Ltd. stands at ₹ 28,060.10 Cr.
What is the dividend yield of Gland Pharma Ltd.?
The dividend yield of Gland Pharma Ltd. is 1.06% based on the current market price.
What is the RSI of Gland Pharma Ltd.?
The Relative Strength Index (RSI) of Gland Pharma Ltd. is 48.61.
What is the FII and DII holding in Gland Pharma Ltd.?
Foreign Institutional Investors (FII) hold 7.90% and Domestic Institutional Investors (DII) hold 31.49% of Gland Pharma Ltd. shares.
What sector does Gland Pharma Ltd. belong to?
Gland Pharma Ltd. operates in the Healthcare sector.
What is the beta of Gland Pharma Ltd. stock?
The beta of Gland Pharma Ltd. stock is 0.69, indicating its volatility relative to the broader market.
